BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30181474)

  • 1. A Valine Mismatch at Position 129 of
    Michita RT; Chies JAB; Schramm S; Horn PA; Heinemann FM; Wunsch A; Viebahn R; Schenker P; Rebmann V
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30181474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
    Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
    Front Immunol; 2018; 9():917. PubMed ID: 29867932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
    Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
    Front Immunol; 2018; 9():926. PubMed ID: 29765374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.
    Isernhagen A; Schilling D; Monecke S; Shah P; Elsner L; Walter L; Multhoff G; Dressel R
    Immunogenetics; 2016 Feb; 68(2):109-23. PubMed ID: 26585323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.
    Isernhagen A; Malzahn D; Viktorova E; Elsner L; Monecke S; von Bonin F; Kilisch M; Wermuth JM; Walther N; Balavarca Y; Stahl-Hennig C; Engelke M; Walter L; Bickeböller H; Kube D; Wulf G; Dressel R
    EMBO Mol Med; 2015 Nov; 7(11):1480-502. PubMed ID: 26483398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICA variant promotes allosensitization after kidney transplantation.
    Tonnerre P; Gérard N; Chatelais M; Poli C; Allard S; Cury S; Bressollette C; Cesbron-Gautier A; Charreau B
    J Am Soc Nephrol; 2013 May; 24(6):954-66. PubMed ID: 23539759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance.
    Hauer V; Risti M; Miranda BLM; da Silva JS; Cidral AL; Pozzi CM; Contieri FLC; Sadissou IA; Donadi EA; Augusto DG; Bicalho MDG
    PLoS One; 2019; 14(2):e0212750. PubMed ID: 30794652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation.
    Baranwal AK; Mehra NK
    Front Immunol; 2017; 8():182. PubMed ID: 28293239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks.
    Isernhagen A; Malzahn D; Bickeböller H; Dressel R
    Front Immunol; 2016; 7():588. PubMed ID: 28018354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MICA expression, anti-MICA antibodies and serum MICA during acute rejection in a rat-to-mouse cardiac transplantation model.
    Yu R; Xu S; Wang Y; Cai H; Xu P
    Int J Clin Exp Pathol; 2015; 8(11):14514-20. PubMed ID: 26823771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.
    Douik H; Ben Chaaben A; Attia Romdhane N; Romdhane HB; Mamoghli T; Fortier C; Boukouaci W; Harzallah L; Ghanem A; Gritli S; Makni M; Charron D; Krishnamoorthy R; Guemira F; Tamouza R
    Hum Immunol; 2009 Jan; 70(1):45-8. PubMed ID: 19000729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population.
    Mariaselvam CM; Boukouaci W; Charron D; Krishnamoorthy R; Tamouza R; Misra DP; Negi VS
    Int J Rheum Dis; 2018 Mar; 21(3):656-663. PubMed ID: 28752674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection.
    Suárez-Alvarez B; López-Vázquez A; Díaz-Molina B; Bernardo-Rodríguez MJ; Alvarez-López R; Pascual D; Astudillo A; Martínez-Borra J; Lambert JL; González S; López-Larrea C
    Transplantation; 2006 Aug; 82(3):354-61. PubMed ID: 16906033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.
    Boukouaci W; Al-Daccak R; Dulphy N; Lauden L; Amokrane K; Fortier C; Marzais F; Bennabi M; Peffault de Latour R; Socie G; Toubert A; Charron D; Krishnamoorthy R; Tamouza R
    Hum Immunol; 2013 Dec; 74(12):1536-41. PubMed ID: 23994587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation.
    Patel SS; Rybicki LA; Yurch M; Thomas D; Liu H; Dean R; Jagadeesh D; Hill B; Pohlman B; Bolwell B; Hanna R; Hamilton BK; Kalaycio M; Gerds AT; Cober E; Mossad S; Zhang A; Majhail NS; Askar M; Sobecks R
    Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):32-39. PubMed ID: 31881183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.
    Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P
    Front Immunol; 2021; 12():633658. PubMed ID: 34012432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study.
    Fechtenbaum M; Desoutter J; Delvallez G; Brochot E; Guillaume N; Goëb V
    Genes Immun; 2019 Sep; 20(7):599-605. PubMed ID: 30177859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.
    Ouni N; Ben Chaaben A; Kablouti G; Lajnef M; Ayari F; Abaza H; Damak T; Harzallah L; Benammar-Elgaaeid A; Guemira F; Tamouza R
    Immunol Invest; 2017 Aug; 46(6):603-614. PubMed ID: 28742417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.